Unsupervised gene expression analyses identify IPF-severity correlated signatures, associated genes and biomarkers.
Wang, Y; Yella, J; Chen, J; McCormack, FX; Madala, SK; Jegga, AG.
BMC Pulmonary Medicine.
2017;
17.
Hsp90 regulation of fibroblast activation in pulmonary fibrosis.
Sontake, V; Wang, Y; Kasam, RK; Sinner, D; Reddy, GB; Naren, AP; McCormack, FX; White, ES; Jegga, AG; Madala, SK.
JCI insight.
2017;
2.
Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data.
Sarangdhar, M; Tabar, S; Schmidt, C; Kushwaha, A; Shah, K; Dahlquist, JE; Jegga, AG; Aronow, BJ.
Nature Biotechnology.
2016;
34:697-700.
Canonical genetic signatures of the adult human brain.
Hawrylycz, M; Miller, JA; Menon, V; Feng, D; Dolbeare, T; Guillozet-Bongaarts, AL; Jegga, AG; Aronow, BJ; Lee, C; Bernard, A; et al.
Nature Neuroscience.
2015;
18:1832-1844.
Concept Modeling-based Drug Repositioning.
Patchala, J; Jegga, AG.
AMIA Joint Summits on Translational Science proceedings AMIA Summit on Translational Science.
2015;
2015:222-226.
Computational drug repositioning through heterogeneous network clustering.
Wu, C; Gudivada, RC; Aronow, BJ; Jegga, AG.
BMC Systems Biology.
2013;
7 Suppl 5:S6-S6.
Drug repositioning for orphan diseases.
Sardana, D; Zhu, C; Zhang, M; Gudivada, RC; Yang, L; Jegga, AG.
Briefings in Bioinformatics.
2011;
12:346-356.
The Orphan Disease Networks.
Zhang, M; Zhu, C; Jacomy, A; Lu, LJ; Jegga, AG.
The American Journal of Human Genetics.
2011;
88:755-766.
ToppGene Suite for gene list enrichment analysis and candidate gene prioritization.
Chen, J; Bardes, EE; Aronow, BJ; Jegga, AG.
Nucleic Acids Research.
2009;
37:W305-W311.
Functional evolution of the p53 regulatory network through its target response elements.
Jegga, AG; Inga, A; Menendez, D; Aronow, BJ; Resnick, MA.
Proceedings of the National Academy of Sciences of USA.
2008;
105:944-949.